Molecular Physiology of Bile Acid Signaling in Health, Disease and Aging
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Physiology of Bile Acid Signaling in Health, Disease and Aging
Authors
Keywords
-
Journal
PHYSIOLOGICAL REVIEWS
Volume -, Issue -, Pages -
Publisher
American Physiological Society
Online
2020-08-14
DOI
10.1152/physrev.00049.2019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
- (2020) Donatella Chianelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids
- (2020) Sarah Ducastel et al. Scientific Reports
- Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
- (2020) Caroline Ovadia et al. Scientific Reports
- Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
- (2020) Clarissa Campbell et al. NATURE
- Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes
- (2020) Gerardo Calderon et al. EBioMedicine
- Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice
- (2019) Patricia D. Finn et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- TGR5 Protects Against Colitis in Mice, but Vertical Sleeve Gastrectomy Increases Colitis Severity
- (2019) Darline Garibay et al. OBESITY SURGERY
- Bile acid supplementation decreases body mass gain in C57BL/6J but not 129S6/SvEvTac mice without increasing energy expenditure
- (2019) Tobias Fromme et al. Scientific Reports
- FXR Regulates Intestinal Cancer Stem Cell Proliferation
- (2019) Ting Fu et al. CELL
- Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
- (2019) Pieter de Groot et al. GUT
- Farnesoid X Receptor alters adipose tissue architecture in mice and limits storage capacity leading to metabolic derangements
- (2019) Tim van Zutphen et al. JOURNAL OF LIPID RESEARCH
- Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids
- (2019) Shuai Wang et al. Microbiome
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Liver Injury in Patients with Cholestatic Liver Disease Treated with Obeticholic Acid
- (2019) John E Eaton et al. HEPATOLOGY
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
- (2019) Mohammad Shadab Siddiqui et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis
- (2018) Michael D. Thompson et al. HEPATOLOGY
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice
- (2018) Takashi Sasaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function
- (2018) Paolo Comeglio et al. JOURNAL OF ENDOCRINOLOGY
- Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation
- (2018) Shinobu Miyazaki-Anzai et al. JOURNAL OF LIPID RESEARCH
- INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
- (2018) Jonathan D Roth et al. WORLD JOURNAL OF GASTROENTEROLOGY
- GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr −/− mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy
- (2018) Anita Patel et al. Molecular Metabolism
- Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass
- (2018) Hening Zhai et al. EBioMedicine
- Fibroblast Growth Factor 15/19 – From Basic Functions to Therapeutic Perspectives
- (2018) Emmanuel Somm et al. ENDOCRINE REVIEWS
- Relationship Between Three Commonly Used Non-invasive Fibrosis Biomarkers and Improvement in Fibrosis Stage in Patients With NASH
- (2018) Naga Chalasani et al. LIVER INTERNATIONAL
- Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids
- (2018) Keita Watanabe et al. PLoS One
- Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism
- (2018) Clea Bárcena et al. Cell Reports
- Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis
- (2018) Adriana Carino et al. FASEB JOURNAL
- FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
- (2018) Elliot S. Friedman et al. GASTROENTEROLOGY
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Metabolite-Sensing G Protein Coupled Receptor TGR5 Protects Host From Viral Infection Through Amplifying Type I Interferon Responses
- (2018) Qingqing Xiong et al. Frontiers in Immunology
- Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice
- (2017) Jan Freark de Boer et al. GASTROENTEROLOGY
- New therapeutic concepts in bile acid transport and signaling for management of cholestasis
- (2017) Michael Trauner et al. HEPATOLOGY
- Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice
- (2017) Oludemilade Akinrotimi et al. HEPATOLOGY
- A dual agonist of farnesoid X receptor (FXR) and the G protein–coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
- (2017) Xiaoxin X. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis
- (2017) Michele Biagioli et al. JOURNAL OF IMMUNOLOGY
- Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III
- (2017) M. Ghosh Laskar et al. JOURNAL OF INTERNAL MEDICINE
- Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
- (2017) David C. Tully et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats
- (2017) Laurens J. Ceulemans et al. PLoS One
- Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice
- (2017) Adriana Carino et al. Scientific Reports
- Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models
- (2016) J. P. Phelan et al. BMC CANCER
- Administration of tauroursodeoxycholic acid enhances osteogenic differentiation of bone marrow-derived mesenchymal stem cells and bone regeneration
- (2016) Byung-Hyun Cha et al. BONE
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
- (2016) Cen Xie et al. DIABETES
- Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
- (2016) R. Pencek et al. DIABETES OBESITY & METABOLISM
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- Microbiota-induced obesity requires farnesoid X receptor
- (2016) Ava Parséus et al. GUT
- G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice
- (2016) Ajay C. Donepudi et al. HEPATOLOGY
- Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice
- (2016) Yang Xu et al. HEPATOLOGY
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Antibiotic effects on gut microbiota and metabolism are host dependent
- (2016) Shiho Fujisaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Gut Microbiota Orchestrates Energy Homeostasis during Cold
- (2015) Claire Chevalier et al. CELL
- Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases
- (2015) Suzanne Devkota et al. DIGESTIVE DISEASES
- Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors
- (2015) Cheryl A. Brighton et al. ENDOCRINOLOGY
- Role of FXR in β-Cells of Lean and Obese Mice
- (2015) Björn Schittenhelm et al. ENDOCRINOLOGY
- TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
- (2015) Maria Reich et al. GUT
- Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2 -deficient mice
- (2015) Mei Zhou et al. HEPATOLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
- (2015) Ulrich Beuers et al. JOURNAL OF HEPATOLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- TGR5 and Immunometabolism: Insights from Physiology and Pharmacology
- (2015) Alessia Perino et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice
- (2015) Daniel A. Briere et al. PLoS One
- Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1
- (2015) Barbara Renga et al. PLoS One
- Novel Mechanistic Insights into Ectodomain Shedding of EGFR Ligands Amphiregulin and TGF- : Impact on Gastrointestinal Cancers Driven by Secondary Bile Acids
- (2014) N. S. Nagathihalli et al. CANCER RESEARCH
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- Cytoplasmic Tyrosine Phosphatase Shp2 Coordinates Hepatic Regulation of Bile Acid and FGF15/19 Signaling to Repress Bile Acid Synthesis
- (2014) Shuangwei Li et al. Cell Metabolism
- Comparative Metabolomics Reveals Endogenous Ligands of DAF-12, a Nuclear Hormone Receptor, Regulating C. elegans Development and Lifespan
- (2014) Parag Mahanti et al. Cell Metabolism
- Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice
- (2014) Susagna Padrissa-Altés et al. GUT
- TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation
- (2014) Alessia Perino et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal transport and metabolism of bile acids
- (2014) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
- (2014) Johannes Schmitt et al. LIVER INTERNATIONAL
- Bile Acid Flux Is Necessary for Normal Liver Regeneration
- (2014) Willscott E. Naugler PLoS One
- A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo
- (2014) Nuruddeen D. Lewis et al. PLoS One
- FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation
- (2014) Jun Yao WORLD JOURNAL OF GASTROENTEROLOGY
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia
- (2013) M. M. Umapathysivam et al. DIABETES
- Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo
- (2013) Magdalena S Mroz et al. GUT
- Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice
- (2013) Iker Uriarte et al. GUT
- Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice
- (2013) Yan Lu et al. GUT
- The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
- (2013) Noémie Péan et al. HEPATOLOGY
- SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling
- (2013) Juan L. García-Rodríguez et al. HEPATOLOGY
- Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR)
- (2013) Wahiba Berrabah et al. HEPATOLOGY
- SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes
- (2013) Natarajan Balasubramaniyan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
- (2013) Rachel H. McMahan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatic glucose sensing is required to preserve β cell glucose competence
- (2013) Pascal Seyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
- (2013) S. Caron et al. MOLECULAR AND CELLULAR BIOLOGY
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- The bile acid receptor, TGR5, regulates basal and cholinergic-induced secretory responses in rat colon
- (2013) J. B. J. Ward et al. NEUROGASTROENTEROLOGY AND MOTILITY
- External biliary drainage and liver regeneration after major hepatectomy
- (2012) R. Otao et al. BRITISH JOURNAL OF SURGERY
- Bile Acids Acutely Stimulate Insulin Secretion of Mouse -Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition
- (2012) M. Dufer et al. DIABETES
- The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control
- (2012) Dimitri J. Pournaras et al. ENDOCRINOLOGY
- Crosstalk between the hepatologist and the cardiologist: A future place for the lithocholic acid as a coronary atheroma risk factor?
- (2012) Henri Duboc et al. HEPATOLOGY
- α5β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes
- (2012) Holger Gohlke et al. HEPATOLOGY
- Cirrhosis and other liver disease in cystic fibrosis
- (2012) Thomas Flass et al. Journal of Cystic Fibrosis
- Farnesoid X Receptor Induces Murine Scavenger Receptor Class B Type I via Intron Binding
- (2012) Guodong Li et al. PLoS One
- Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
- (2012) Mitsuhiro Watanabe et al. PLoS One
- A Steroid Receptor-MicroRNA Switch Regulates Life Span in Response to Signals from the Gonad
- (2012) Y. Shen et al. SCIENCE
- Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion
- (2011) HE Parker et al. BRITISH JOURNAL OF PHARMACOLOGY
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
- (2011) Matthew J. Potthoff et al. Cell Metabolism
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- Molecular Control of Systemic Bile Acid Homeostasis by the Liver Glucocorticoid Receptor
- (2011) Adam J. Rose et al. Cell Metabolism
- Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis
- (2011) Salvatore Modica et al. GASTROENTEROLOGY
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes
- (2011) Elaine Studer et al. HEPATOLOGY
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
- (2011) Rian M. Nijmeijer et al. PLoS One
- Dose-Response of Five Bile Acids on Serum and Liver Bile Acid Concentrations and Hepatotoxicty in Mice
- (2011) Peizhen Song et al. TOXICOLOGICAL SCIENCES
- The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity
- (2010) Iuliana Ristea Popescu et al. FEBS LETTERS
- Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
- (2010) Zhao-Xia Yang et al. Hepatology International
- Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice
- (2010) Anne Laure Sberna et al. JOURNAL OF HEPATOLOGY
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
- (2010) G. Rizzo et al. MOLECULAR PHARMACOLOGY
- The normal mechanisms of pregnancy-induced liver growth are not maintained in mice lacking the bile acid sensor Fxr
- (2009) Alexandra Milona et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation
- (2009) J. Miao et al. GENES & DEVELOPMENT
- Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
- (2009) Yanqiao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
- (2009) Sushant Bhatnagar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Bile acid transporters
- (2009) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
- (2009) Brenton Flatt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies
- (2008) Hiroyuki Sato et al. JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started